|
|
Sales Performance
The basis of most reports starts with sales performance. It
can start at the global
level and then work down to an individual product within
a specific market. Cash, units or scripts can record sales
and market shares can be produced for all therapeutic areas.
With this, each aspect of companies sales performance can
be seen to reveal strengths and weaknesses worldwide.
Product Pipeline
Quantitative and evaluated information on the products in research,
shows which therapy classes the company is concentrating its
resources on, and which new drugs it will bring to market
in the near and medium term.
Patent Portfolio
Insight into the company's
patent portfolio shows how vulnerable the company is to
generic competition, as the patents of its product reach expiry.
Product Monitoring On a day-to-day basis, checking for new drugs coming
to the market is important, if the share of existing products
is to be protected and then tracking new drug sales on a monthly basis.
Analysing the key
components of a company including strategy, financial
and corporate structure puts all this competitive information
into context.
|
